North Carolina HB 607: Regulate Hemp Consumable Products.

Bill Text

GENERAL ASSEMBLY OF NORTH CAROLINA
SESSION 2025
H 1
HOUSE BILL 607

Short Title: Regulate Hemp Consumable Products. (Public)
Sponsors: Representatives McNeely and Chesser (Primary Sponsors).
For a complete list of sponsors, refer to the North Carolina General Assembly web site.
Referred to: Rules, Calendar, and Operations of the House
April 1, 2025
*H607-v-1*
A BILL TO BE ENTITLED 1
AN ACT TO REGULATE THE SALE AND DISTRIBUTION OF HEMP-DERIVED 2
CONSUMABLE PRODUCTS. 3
The General Assembly of North Carolina enacts: 4
SECTION 1.(a) The General Statutes are amended by adding a new Chapter to read: 5
"Chapter 18D. 6
"Regulation of Hemp-Derived Consumable Products. 7
"Article 1. 8
"Regulation of Hemp-Derived Consumable Products. 9
"§ 18D-100. Definitions. 10
Unless the context requires otherwise, the following definitions apply in this Chapter: 11
(1) ALE Division. – The Alcohol Law Enforcement Division of the Department 12
of Public Safety. 13
(2) Batch. – The hemp-derived consumable product produced during a period of 14
time under similar conditions and identified by a specific code that allows 15
traceability. 16
(3) Distributor. – A person or entity that delivers or sells hemp-derived 17
consumable products for the purpose of distribution in commerce. 18
(4) Exit package. – An opaque bag or other similar opaque covering provided at 19
the point of sale that satisfies the child-resistant effectiveness standards under 20
16 C.F.R. § 1700.15(b)(1) when tested in accordance with the requirements 21
of 16 C.F.R. § 1700.20 in which hemp-derived consumable products are 22
placed by a seller after being sold to the ultimate consumer of the product. 23
(5) Hemp. – As defined in G.S. 90-87. 24
(6) Hemp-derived cannabinoid. – Any phytocannabinoid found in hemp, 25
including delta-9 tetrahydrocannabinol (delta-9 THC), tetrahydrocannabinolic 26
acid (THCA), cannabidiol (CBD), cannabidiolic acid (CBDA), cannabinol 27
(CBN), cannabigerol (CBG), cannabichromene (CBC), cannabicyclol (CBL), 28
cannabivarin (CBV), tetrahydrocannabivarin (THCV), cannabidivarin 29
(CBDV), cannabicitran (CBT), delta-7 tetrahydrocannabinol (delta-7 THC), 30
delta-8 tetrahydrocannibinol (delta-8 THC), or delta-10 tetrahydrocannibinol 31
(delta-10 THC). This term also includes any synthetic cannabinoid derived 32
from hemp and contained in a hemp-derived consumable product. 33
(7) Hemp-derived consumable product. – A hemp product that is a finished good 34
intended for human ingestion or inhalation that contains a delta-9 THC 35

General Assembly Of North Carolina Session 2025
Page 2 House Bill 607-First Edition
concentration of not more than three-tenths of one percent (0.3%) on a dry 1
weight basis, but may contain concentrations of other hemp-derived 2
cannabinoids, in excess of that amount. This term does not include hemp 3
products intended for topical application, or seeds or seed-derived ingredients 4
that are generally recognized as safe by the United States Food and Drug 5
Administration (FDA). 6
(8) Hemp product. – As defined in G.S. 90-87. 7
(9) Independent testing laboratory. – A laboratory that meets all of the following 8
conditions: 9
a. Holds an ISO 17025 accreditation or is registered with the Drug 10
Enforcement Administration (DEA) in accordance with 21 C.F.R. § 11
1301.13. 12
b. Does not have a direct or indirect interest in the entity whose product 13
is being tested. 14
c. Does not have a direct or indirect interest in a facility that cultivates, 15
processes, distributes, dispenses, or sells hemp-derived consumable 16
products in this State or any other jurisdiction. 17
d. Has entered into a compliance agreement with the ALE Division to 18
conduct tetrahydrocannabinol concentration sampling and testing 19
using the high-performance chromatography (HPLC) testing method. 20
(10) Ingestion. – The process of consuming hemp through the mouth, by 21
swallowing into the gastrointestinal system or through tissue absorption. 22
(11) Inhalation. – The process of consuming hemp into the respiratory system 23
through the mouth or nasal passages. 24
(12) License. – A license issued in accordance with this Chapter. 25
(13) Licensee. – A person who has been issued a license in accordance with this 26
Chapter. 27
(14) Manufacture. – To compound, blend, extract, infuse, cook, or otherwise 28
manipulate hemp or a hemp-derived cannabinoid to make, prepare, or package 29
hemp-derived consumable products. 30
(15) Manufacturer. – Any person or entity that engages in the process of 31
manufacturing, preparing, or packaging of hemp-derived consumable 32
products. 33
(16) Producer. – Any person or entity that engages in the process of farming and 34
harvesting hemp that is intended to be used in the manufacture of a 35
hemp-derived consumable product. 36
(17) Retail dealer. – Any person who sells a hemp-derived consumable product to 37
the ultimate consumer of the product, including a remote seller. 38
(18) Serving. – A quantity of a hemp-derived cons